Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

5 terminated/withdrawn out of 402 trials

Success Rate

93.1%

+6.5% vs industry average

Late-Stage Pipeline

11%

44 trials in Phase 3/4

Results Transparency

0%

0 of 67 completed trials have results

Key Signals

95 recruiting

Enrollment Performance

Analytics

N/A
108(41.7%)
Phase 2
60(23.2%)
Phase 1
41(15.8%)
Phase 4
24(9.3%)
Phase 3
20(7.7%)
Early Phase 1
6(2.3%)
259Total
N/A(108)
Phase 2(60)
Phase 1(41)
Phase 4(24)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (402)

Showing 20 of 402 trials
NCT07619989Not ApplicableRecruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

Role: lead

NCT07732777Not ApplicableRecruiting

AI-Assisted Remote Insulin Pump Optimization in T1DM

Role: lead

NCT07735065Phase 1Not Yet Recruiting

Tumor-Specific T-Cells (cCTL:GL01) for Advanced Gastrointestinal Cancer

Role: lead

NCT07723053Not ApplicableNot Yet Recruiting

Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosis

Role: lead

NCT07721532Active Not Recruiting

Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

Role: lead

NCT05313529Not ApplicableCompleted

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Role: lead

NCT07711314Phase 2Recruiting

Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy

Role: lead

NCT07700524Not Yet Recruiting

Intraoperative Portable Ultrasound for Real-Time Graft Perfusion Assessment During CABG: A Randomized Controlled Trial

Role: lead

NCT07657520Recruiting

High-Altitude Neurodegeneration Cohort (HANC) Study

Role: collaborator

NCT07562763Completed

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Role: collaborator

NCT07692672Phase 3Not Yet Recruiting

Intrauterine G-CSF Infusion for Thin Endometrium

Role: collaborator

NCT07690878Phase 2Not Yet Recruiting

PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer

Role: lead

NCT07683832Early Phase 1Not Yet Recruiting

Safety, Tolerability, Immunogenicity, Pharmacodynamic Characteristics, and Preliminary Anti-tumor Activity of Personalized Cancer Vaccines Alone and in Combination With Toripalimab in Participants With Resected NSCLC

Role: lead

NCT07677566Phase 4Not Yet Recruiting

177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Role: lead

NCT06674226Phase 4Completed

Effects of Ciprofol on Postoperative Delirium and Outcomes in Elderly Patients Undergoing Major Thoracic Surgery

Role: collaborator

NCT06946485Early Phase 1Recruiting

Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus

Role: lead

NCT07666698Phase 1Not Yet Recruiting

A Study of Metformin to Improve Cardiac Function After LVAD Implantation

Role: lead

NCT06968806Phase 3Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Role: lead

NCT07274644Phase 4Active Not Recruiting

Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease

Role: lead

NCT07517536Not ApplicableEnrolling By Invitation

CHT105 for the Treatment of Refractory Lupus Nephritis

Role: lead